- 52 min ago Omicron: German Capital Berlin Turns Into COVID Hotspot
- 1 hr ago Expert Opinion: Maharashtra's New Guidelines For Sensitive Handling Of Crimes Against Women & Children
- 8 hrs ago Greek Artist Alekos Fassianos Passes Away: Tribute
- 9 hrs ago What Is A Mucus Plug? What Does Losing Your Mucus Plug Mean During Pregnancy?
- Movies International Film Festival Of Kerala IFFK 2022 Postponed Due To COVID Surge
- Technology Amazon Great Republic Day Sale: Top Discount Offers On Intel Core i7 Laptops
- Sports Ben Stokes opts out of IPL 2022 auctions to stay fresh for English home summer: Reports
- Finance First IPO Of 2022 To Open On January 19, 2022: Know Key Points
- News I can beat up Modi: Congress leader's video kicks up controversy
- Education CBSE Science Challenge 2021-22 Announced For Students Of Class 8 To Class 10. Check Details Here
- Automobiles Citroen C3 Debuts In ‘Messi’ Land: India Launch Soon
- Travel Amazing Places To Visit In West Bengal In Winter Of 2022
As many as 300 districts in India are reporting weekly COVID-19 case positivity of more than 5%, the Union government said on January 12 as it urged people not to treat infection due to Omicron variant as the common cold and get vaccinated.
It said Maharashtra, West Bengal, Delhi, Tamil Nadu, Karnataka, Uttar Pradesh, Kerala and Gujarat are emerging as States of concern due to the rise in COVID-19 cases.
Addressing a press conference, Joint Secretary in Health Ministry Lav Agarwal said a sharp rise in COVID-19 infections has been noted in India with the case positivity climbing to 11.05% on Wednesday from 1.1% on December 30.
Concurrently, COVID-19 cases have been rising globally with January 10 recording the highest ever single-day rise of 31.59 lakh cases worldwide, he said.
The official said that currently, 300 districts in India are reporting weekly case positivity of more than 5%.
Informing the press conference that 19 States have over 10,000 active COVID cases, Mr Agarwal said Maharashtra, West Bengal, Delhi, Tamil Nadu, Karnataka, Uttar Pradesh, Kerala and Gujarat are emerging as States of concern due to the rise in COVID cases there.
Stressing on the importance of getting inoculated, he quoted the World Health Organisation to say that vaccine effectiveness against hospitalisation appears to be substantially higher than against symptomatic COVID-19 disease.
NITI Aayog Member (Health) V. K. Paul said, "Omicron is not the common cold, cannot take it lightly. We need to be vigilant, get vaccinated and follow Covid-appropriate behaviour." "Vaccination is an important pillar in our Covid response programme," he added.
India added 1,94,720 new infections to its tally of COVID-19 cases pushing it to 3,60,70,510, according to the Union Health Ministry data on Wednesday.
Active cases have increased to 9,55,319, the highest in 211 days, while the death toll has climbed to 4,84,655 with 442 fresh fatalities. Of the total 4,868 cases of the Omicron variant, 1,805 people have recovered or migrated so far.
- healthPhytochemicals Discovered In Himalayan Plant Buransh That Inhibit COVID-19 Virus
- healthOmicron Viral Load At Its Highest On Day 5? A Scientific Understanding Of The Isolation Period
- healthIndia Records 2,58,089 New Covid Infections Including 8,209 Omicron Cases, 385 Deaths
- healthDelta Still Dominant Strain Of COVID-19, Says Maharashtra Health Official Amid Omicron Scare
- womenMithali Raj And Indian Women's Cricket Team To Quarantine In Mumbai Ahead Of Women's World Cup 2022 Departure
- wellnessDeadly Delta Wave Stole 2,40,000 Lives In India, 'Similar Episodes' Could Take Place Soon: UN Report
- healthMedia Reports Claiming Under-Reporting Of COVID Deaths Ill-Informed, Baseless & Misleading: Govt
- healthAstrazeneca Vaccine As Third Dose Effective Against Omicron: Study
- healthIndia Reports 2,47,417 New Coronavirus Cases, Highest Since May 2021
- kidsRajasthan Govt Defers Class 12 Practical Exams Due To Spike In COVID Cases
- wellnessCoronavirus Loses 90% Ability To Infect After Being Exposed To Air In Just 20 Minutes: Study
- wellnessPaxlovid: South Korea Gets First Supply Of Pfizer's COVID-19 Pills; Read Details